Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
2,361,876
-
Share change
-
+285,668
-
Total reported value
-
$8,456,000
-
Price per share
-
$3.58
-
Number of holders
-
12
-
Value change
-
+$1,081,865
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q1 2019
As of 31 Mar 2019,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,361,876 shares.
The largest 10 holders included
Hikari Power Ltd, NEA Management Company, LLC, Vivo Capital, LLC, Virtu Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, Parallax Volatility Advisers, L.P., and Truvestments Capital LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.